Abstract:
In an upper tool for a press brake clamped between a support plate (7) of an upper tool holder body (5) attached to a lower portion of an upper table (3) and an upper tool clamp member (11), the upper tool (9) is formed with an inclined surface (9S) narrowed upward at an upper portion thereof and with an engage groove (9G) engaged with an engage projection (11K) of the upper tool clamp member (11) and formed under the inclined surface (9S). Therefore, the inclined surface (9S) is brought into contact with an inclined surface of the upper tool clamp member (11), when the upper tool is clamped between the upper tool holder body (5) and the upper tool clamp member (11), in such a way that clamping force can be-further increased when the upper tool is engaged with a die (63). Further, in an upper tool holder apparatus for a press brake, the pivotal upper tool clamp member (211) is formed with an engage projection (211P) engaged with a drop prevention groove (205G) formed in the upper tool (205), and the upper tool holder apparatus further comprises clamp operation lever (215) for selectively moved to a clamp position A at which the clamping force can be applied to the upper tool clamp member (211) from the clamping force generating spring (213) to clamp the upper tool tightly; an unclamp position B at which the clamping force can be reduced to allow the upper tool to be adjustably shifted horizontally, and an exchange position C at which the upper tool clamp member (211) can be moved way from the upper tool to allow the upper tool to be exchanged vertically with another one.
Abstract:
An anti-inflammatory drug comprising as the effective component at least one compound selected from the group consisting of colominic acid, partial hydrolysis products of colominic acid and pharmaceutically acceptable salts thereof. The drug is used as a drug for renal diseases, a drug for hepatitis, an immunomodulator and a drug for inhibiting the chemotaxis of neutrophil.
Abstract:
Method for the production of asialoganglioside related compounds of the formula (I). ##STR1## wherein R.sup.1 is hydrogen or benzoyl, R.sup.2 is hydrogen or acetyl, R.sup.3 is hydrogen, acetyl, .beta.-D-galactopyranosyl or 2,3,4,6-tetra-O-acetyl-.beta.-D-galactopyranosyl, R.sup.7 and R.sup.8 are individually alkyl having 1 to 30 carbon atoms and Ac is acetyl.
Abstract:
The present invention relates to sialic acid derivatives. According to the present invention, there is provided sialic acid derivatives having the general formula (I): ##STR1## wherein, R.sup.1 represents hydrogen, an acetyl group, a trityl group, ##STR2## (R.sup.5 represents hydrogen or an acetyl group and R.sup.6 represents hydrogen, sodium or a methyl group).R.sup.2 represents hydrogen or an acetyl group,one of R.sup.3 and R.sup.4 represents ##STR3## (R.sup.7 represents a hydrogen atom or an acetyl group, R.sup.8 represents a hydrogen atom, an acetyl group or a benzyl group, R.sup.9 represents a hydrogen atom, an acetyl group, a benzyl group or ##STR4## wherein R.sup.10 represents a hydrogen atom or a benzoyl group), while the other represents --COOR.sup.11 wherein R.sup.11 represents hydrogen, sodium, or a methyl group.
Abstract:
A method of producing a superconducting wire including A-B-C-D system oxide superconductor wherein A is an at least one element of group IIIa of the Periodic Table, B is an at least one alkali earth metal, C includes Cu and D includes O. In the method, a material containing at least one of both A and B is arranged inside or outside an elongated tubular coating layer, which includes a copper alloy and at least the other one, to form a composite element. Then, the composite element undergoes a heat treatment to produce the superconductor.
Abstract:
This invention provides a novel compound having a formula such as ##STR1## This invention also provides a process for preparing such a compound.
Abstract:
A wafer box having a variable wafer slot size including a wafer box body of a rectangular parallelpiped shape having parallel wafer inserting grooves formed in inner side surfaces thereof extending in a vertical direction, a plurality of parallel fixing plate inserting grooves formed in the end surfaces and extending in a vertical direction, and an open upper part. At least one fixing plate, also having a plurality of wafer receiving grooves formed on at least one surface thereof, is inserted into a selected pair of the fixing plate inserting grooves. Both ends of the plate are shaped so as to be easily insertable and removable. Buffer members are placed between the side surfaces in the upper and lower portions of the box to support the wafers from the upper and lower sides thereof. A closure covers the upper part of the box.
Abstract:
The brushless motor includes a stator having a electromagnetic coil and a position sensor; an axis fixed to the stator; and a rotor having a permanent magnet. The rotor rotates around the axis. The rotor is linked to a driven member that is driven by the brushless motor.
Abstract:
The single-phase brushless motor according to one aspect of the present invention includes a coil array having a plurality of magnetic coils 11-14; a magnet array having a plurality of permanent magnets 31-34; a magnetic sensor 40 for detecting relative position of the magnet array and the coil array; and a drive control circuit that, utilizing the output signal SSA of the magnetic sensor, generates application voltage for driving the coil array with a single-phase drive signal. The coil array includes a magnetic member 20. This magnetic member 20 is constituted such that, with the single-phase brushless motor at a stop, the centers of the permanent magnets 31-34 come to a stop at locations offsetted from the centers of the magnetic coils 11-14, due to attraction of the magnetic member 20 by the magnet array.
Abstract:
In order to provide the anti-retrovirus active compound with low anti-coagulant action and low cytotoxicity, compounds comprising glycoside or the salt thereof wherein lipid is linked to position 2 of sialic acid having all hydroxyl groups at positions 4, 7, 8 and 9 completely sulfated, or KDN (2-keto-3-deoxy-D-glycero-2-nononic acid) having all hydroxyl groups at positions 4, 5, 7, 8 and 9 completely sulfated are provided.